Brief Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 28, 2011; 17(12): 1642-1648
Published online Mar 28, 2011. doi: 10.3748/wjg.v17.i12.1642
Table 1 Clinicopathological data of the patients with colorectal adenocarcinoma n (%)
Younger group (n = 68)Elderly group (n = 54)P value
SexNS
Male/female40 (58.8)/28 (41.2)28 (51.9)/26 (48.1)
Age (yr) (mean ± SD)62.2 ± 8.680.4 ± 5.0NS
BMI (kg/m2) (mean ± SD)22.2 ± 3.321.1 ± 3.60.035
Localization of tumor lesionNS
C3 (4.4)3 (5.6)
A9 (13.2)18 (33.3)
T8 (11.8)8 (14.8)
D3 (4.4)1 (1.9)
S26 (38.2)11 (20.4)
R20 (29.4)14 (25.9)
ASA0.01
 I39 (57.4)12 (22.2)
II22 (32.4)31 (57.4)
III6 (8.8)11 (20.4)
IV1 (1.5)0 (0)
Type of tumorNS
06 (8.8)1 (1.9)
16 (8.8)7 (13.0)
252 (76.5)44 (81.5)
35 (7.4)4 (7.4)
Histological typeNS
Papillary adenocarcinoma1 (1.5)2 (3.7)
Tubular adenocarcinoma (tub1/tub2)29 (42.6)/33 (48.5)17 (31.5)/28 (51.9)
Poorly differentiated adenocarcinoma3 (4.4)5 (9.3)
Mucinous adenocarcinoma2 (2.9)2 (3.7)
T StageNS
T1 (m, sm)0 (0)/7 (10.3)1 (1.9)/2 (3.7)
T2 (mp)15 (22.1)8 (14.8)
T3 (ss, a)16 (23.5)/14 (20.6)19 (35.2)/9 (16.7)
T4 (se, si, ai)13 (19.1)/3 (4.4)/0 (0)11 (20.4)/4 (7.4)/0 (0)
N StageNS
N039 (57.4)30 (55.6)
N121 (30.9)13 (24.1)
N24 (5.9)5 (9.3)
NX4 (5.9)6 (11.1)
MetastasesNS
M061 (89.7)49 (90.7)
M17 (10.3)5 (9.3)
StageNS
00 (0)1 (1.9)
 I17 (25.0)8 (14.8)
II20 (29.4)22 (40.7)
III23 (33.8)17 (31.5)
IV8 (11.8)6 (11.1)
Comorbidity
OverallPresent27 (39.7)36 (66.7)0.003
Absent41 (60.3)18 (33.3)
Cardiovascular diseasesPresent6 (8.8)14 (25.9)0.011
Absent62 (91.2)40 (74.1)
HypertensionPresent10 (14.7)19 (35.2)0.008
Absent58 (85.3)35 (64.8)
Diabetes mellitusPresent5 (7.4)3 (5.6)NS
Absent63 (92.6)51 (94.4)
Cerebrovascular diseasesPresent3 (4.4)5 (9.3)NS
Absent65 (95.6)49 (90.7)
Other diseasesPresent6 (8.8)7 (13.0)NS
Absent62 (91.2)47 (87.0)